FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention proposes a pharmaceutical composition designated for pain treatment in mammal. Composition contains gabapentin or pregabalin and α-aminoamide. Α-Aminoamide is chosen from the group consisting of (S)-(+)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide, (R)-(-)-2-[4-benzyloxybenzylamino]-3-phenyl-N-methylpropanamide and (S)-(+)-2-[4-(3-fluorobenzyloxy)benzylamino]-N-methylpropanamide as a single isomer or their mixture. Pharmaceutical composition provides synergistic effect of corresponding analgesic activities without accompanying enhancing symptoms of by-side effects.
EFFECT: valuable medicinal properties of pharmaceutical composition.
6 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMBINATION | 2009 |
|
RU2571501C2 |
| PHARMACEUTICAL COMBINATION | 2009 |
|
RU2674150C1 |
| ALPHA-AMINOAMIDE DERIVATIVES USED AS ANTIMIGRAINE AGENTS | 2003 |
|
RU2336077C2 |
| METHOD OF USAGE OF (HALO BENZYLOXY)BENZYLAMINO-PROPANAMIDE FOR PRODUCTION OF MEDICATIONS WITH SELECTIVE MODULATING ACTIVITY ON SODIUM AND/OR CALCIUM CHANNELS | 2005 |
|
RU2391973C2 |
| ALPHA-AMINOAMIDE DERIVATIVES USED FOR TREATING LOWER URINARY TRACT DISORDERS | 2005 |
|
RU2395504C2 |
| α -AMINOAMIDE DERIVATIVES APPLICABLE AS ANTI-INFLAMMATORY AGENTS | 2004 |
|
RU2396251C2 |
| TAPENTADOL COMPOSITIONS FOR PAIN MANAGEMENT | 2008 |
|
RU2497512C2 |
| COMBINATIONS CONTAINING ALPHA-2-DELTA LIGANDS AND SEROTONIN/NORADRENALINE REUPTAKE INHIBITORS | 2004 |
|
RU2320369C2 |
| PHARMACEUTICAL COMBINATION AND USING IT | 2011 |
|
RU2575775C2 |
| APPLICATION OF ZOLEDRONE ACID, ITS SALTS, HYDRATES AND METHOD OF ANTINOCICEPTIVE OR ANTIALLODYNIC TREATMENT OF PAIN, METHOD OF NEUROTIC PAIN TREATMENT | 2001 |
|
RU2325913C2 |
